Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: Preferential enhancement of "triangulation" in LQT1

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 3, 2005, Pages 219-227

  Viitasalo, Matti ^a,b   Paavonen, Kristian J ^b   Swan, Heikki ^a   Kontula, Kimmo ^b   Toivonen, Lauri ^a  

^a Department of Cardiology ^*  (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Electrocardiography; Long QT syndrome

Indexed keywords

ADRENALIN; PHENYLEPHRINE;

ACTION POTENTIAL DURATION; ADOLESCENT; ADRENERGIC SYSTEM; ADULT; ARRHYTHMOGENESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC INTERVAL; DRUG EFFECT; FEMALE; HEART ATRIUM PACING; HEART ATRIUM SEPTUM; HEART MUSCLE POTENTIAL; HEART RATE; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME TYPE 1; LONG QT SYNDROME TYPE 2; MALE; MORPHOLOGY; QT INTERVAL; QTC INTERVAL;

ACTION POTENTIALS; ADOLESCENT; ADRENERGIC AGONISTS; ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; EPINEPHRINE; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LEAST-SQUARES ANALYSIS; LONG QT SYNDROME; MALE; MIDDLE AGED;

EID: 15344351397     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.09404.x     Document Type: Article

References (33)

1. Schwartz PJ, Priori SG, Napolitano C. The long QT syndrome. In: Zipes DP, Jalife J (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA, W.B. Saunders; 2000, pp. 597-615.
2. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long QT syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89-95.
3. Hondeghem LM, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001; 103:2004-2013.
4. Franz MR. Monophasic action potentials recorded by contact electrode method: Genesis, measurements, and interpretations. In: Franz MR (ed.): Monophasic Action Potentials: Bridging Cell and Bedside. New York, Futura Publishing Company; 2000: pp.19-45.
5. Saarinen K, Swan H, Kainulainen K, et al. Molecular genetics of the long QT syndrome: Two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred. Hum Mutat 1998; 11:158-165.
6. Laitinen P, Fodstad H, Piippo K, et al. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat 2000; 15:580-581.
7. Piippo K, Swan H, Pasternack M, et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: Implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol 2001; 37:562-568.
8. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983; 51:1629-1634.
9. Morady F, Nelson SD, Kou WH, et al. Electrophysiologic effects of epinephrine in humans. J Am Coll Cardiol 1988; 11:1235-1244.
10. Laurita KR, Girouard SD, Rosenbaum DS. Modulation of ventricular repolarization by a premature stimulus: Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea pig heart. Circ Res 1996; 79:493-503.
11. Hirao H, Shimizu W, Kurita T, et al. Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome. J Am Coll Cardiol 1996; 28: 1269-1277.
12. Shimizu W, Ohe T, Kurita T, et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995; 26:1299-1309.
13. + channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 1998; 97:1581-1588.
14. Tanabe Y, Inagaki M, Kurita T, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2001; 37:911-919.
15. Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77:413-421.
16. Noda T, Takaki H, Kurita T, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 2002; 23:975-983.
17. Ks heterogeneity on action potential duration and its rate dependence. A simulation study. Circulation. 1999; 99:2466-2474.
18. Hume JR, Harvey RD. Chloride conductance pathways in heart. Am J Physiol 1991; 261:C399-C412.
19. Zygmunt AC. Intracellular calcium activates chloride current in canine ventricular myocytes. Am J Physiol 1994; 267:H1984-H1995.
20. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: Effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and Torsade de Pointes. Circulation 1998; 98:2314-2322.
21. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de Pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997; 96:2038-2047.
22. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmiac agents. J Gen Physiol. 1990; 96:195-215.
23. Zeng J, Laurita KR, Rosenbaum DS, et al. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type: Theoretical formulation and their role in repolarization. Circ Res 1995; 77:140-152.
24. Zaniboni M, Pollard AE, Yang L, et al. Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol 2000; 278:H677-H687.
25. Yamauchi S, Yamaki M, Watanabe T, et al. Restitution properties and occurrence of ventricular arrhythmia in LQT2 type of long QT syndrome. J Cardiovasc Electrophysiol 2002; 13:910-914.
26. Rudy J. Ionic mechanisms of cardiac electrical activity. In: Zipes DP, Jalife J (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA, W.B. Saunders; 2000, pp. 257-265.
27. Schreieck J, Wang YG, Gjini V, et al. Differential effect of beta-adrenergic Stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide and chromanol 293B. J Cardiovasc Electrophysiol 1997; 8:1420-1430.
28. Qu Z, Weiss JN, Garfinkel A. Cardiac electrical restitution properties and stability of reentrant spiral waves: A simulation study. Am J Physiol 1999; 276:H269-H283.
29. Weiss JN, Garfinkel A, Karagueuzian HS, et al. Chaos and the transition to ventricular fibrillation: A new approach to antiarrhythmic drug evaluation. Circulation 1999; 99:2819-2826.
30. Hirayama Y, Saitoh H, Atarashi H, et al. Electrical and mechanical alternans in canine myocardium in vivo. Dependence on intracellular calcium cycling. Circulation 1993; 88:2894-2902.
31. Fox JJ, McHarg JL, Gilmoui RF Jr. Ionic mechanism of electrical alternans. Am J Physiol 2002; 282:H516-H530.
32. Taggart P, Sutton P, Chalabi Z, et al. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 2003; 107:285-289.
33. Franz MR, Swerdlow CD, Liem LB, et al. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988; 82:972-979.